News & Events

Events

  • 15 Oct. 2018 / 5:30 pm
    Biohouse (Ein Carem Campus)

    From Molecule to Drug

    THE PROGRAM:

    • Dr. Shai Melcer – Opening words.
    • Dr. Sylvia Kachalsky and Dr. Tamar Raz – Introduction to Recipharm Israel and Hadasit partnership.
    • Dr. Tamar Raz – Selection of indication and its importance in drug development.
    • Dr. Helen Domeshek – Innovation in Bioanalysis: dry blood spot method.
    • Dr. Rephael Nudelman – Impurity qualification and drug development process.

    TO RESERVE YOUR FREE PLACE, EMAIL:
    helen.domeshek@recipharm.com

  • 30 May. 2018 / 4:00 pm
    Tourism Auditorium Hadassah Ein-Karem

    From B2B: From Bench to Billions

    Agenda:

    16:00-17:00  – Welcome Reception
    Food & Wine

    17:00-17:15 – Greetings
    Prof. Zeev Rotstein, Director General, Hadassah Medical Organization
    Dr. Tamar Raz, CEO, Hadasit Ltd.

    17:15-17:45
    Dr. Noga Yerushalmi, Head of Israel Bio-incubator, HealthCare Fund, M.Ventures – “M. Ventures – Beyond Imagination”

    17:45-18:45
    Keynote Speaker – Dr. Sol Barer
    Founder and Former Chairman and CEO of Celgene (NASDAQ:CELG), and Chairman of the Board, TEVA. – “Building a Biotechnology Company: Lessons from Celgene”